Just in December, six companies have announced the launch of their denosumab biosimilars in Europe: Sandoz, Samsung Bioepis, Fresenius Kabi, ...
BCVA is inadequate for detecting visual disturbances in conditions like MacTel, which initially affect the parafoveal region.
Chugai Pharma announces 48-week NIHONBASHI phase III study results presented at JRVS meeting show that Vabysmo sustained vision improvements in Japanese patients with angioid streaks ...
Background To determine whether dynamic changes in choroidal thickness (CT) cause shallowing of the anterior chamber. Methods 34 healthy volunteers were enrolled. The participants in our study adopted ...
Myopic progression and the development of pathological myopia are not only a concern in children, but in young highly myopic adults. According to new research in the British Journal of Ophthalmology, ...
Objective: To evaluate the diagnostic accuracy of optical coherence tomography angiography for the identification of choroidal neovascularization in age-related macular degeneration. Methods: This ...
Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that demonstrate the potential of TECVAYLI® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback